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http://dxObjective: Valve sparing root replacement (VSRR) is an attractive option for the management of aortic root
aneurysms with a normal native aortic valve. Therefore, we reviewed our experience with a modification of
the David VVSRR and compared it with stented pericardial bioprosthetic valve conduit (BVC) root replacement
in an age-matched cohort of older patients.
Methods: A total of 48 VSRRs were performed at our institution, excluding those on bicuspid aortic valves.
We compared these cases with 15 aortic root replacements performed using a BVC during the same period.
Subgroup analysis was performed comparing 16 VSRR cases and 15 age-matched BVC cases.
Results: The greatest disparity between the VSRR and BVC groups was age (53 vs 69 years, respectively;
P < .0005). The matched patients were similar in terms of baseline demographics and differed only in
concomitant coronary artery bypass grafting (2 VSRR vs 7 BVC patients; P ¼ .036). None of the VSRR and
3 of the BVC procedures were performed for associated dissection (P¼ .101). Postoperative aortic insufficiency
gradewas significantly different between the 2 groups (P¼ .004). The cardiopulmonary bypass, crossclamp, and
circulatory arrest times were not different between the VSRR and BVC groups (174 vs 187 minutes, P ¼ .205;
128 vs 133minutes, P¼ .376; and 10 vs 13minutes, respectively;P¼ .175). No differences were found between
the 2 groups with respect to postoperative complications. One postoperative death occurred in the BVC group
and none in the VSRR group. The postoperative length of stay and aortic valve gradients were less in the VSRR
group (6 vs 8 days, P¼ .038; 6 vs 11.4 mmHg, P¼ .001). The intensive care unit length of stay was significantly
less in the VSRR group (54 vs 110 hours, P ¼ .001).
Conclusions: VSRR is an effective alternative to the BVC for aortic root aneurysm. (J Thorac Cardiovasc Surg
2014;148:2883-7)A
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DSince the original description of the use of a mechanical
valve conduit for replacement of the aortic valve and
ascending aorta by Wheat and colleagues1 and then Bentall
and De Bono,2 an evolution of aortic root surgery has
resulted in a movement to preserve the valve during root
replacement. Patients requiring aortic root replacement
for aneurysmal disease have historically been treated by
complete excision of the aneurysm and valve, followed by
replacement with a composite valve conduit (biologic or
mechanical) or homograft aortic root. David and Feindel3
and Sarsam and Yacoub4 described techniques for
valve sparing root replacement (VSRR), with multiple
subsequent iterations for use in patients with aortic root
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The Journal of Thoracic and Carof the native valve could avoid the potential complications
related to the use of mechanical or bioprosthetic tissue
valves, including freedom from anticoagulation and the
theoretical risk of structural valve deterioration.
Accordingly, VSRR is an attractive treatment of aortic
root aneurysm with a normal aortic valve for the initiated
surgeon. Although technically more demanding, excellent
early and late outcomes after VSRR have been reported.5
Very few published reports comparing modern VSRR
and bioprosthetic valve conduits (BVCs) are available.
Therefore, we reviewed our experience with a modification
of the David V VSRR and compared it with stented
pericardial BVC root replacement in an age-matched cohort
of older patients.METHODS
FromMarch 2003 to December 2012, 70 patients underwent VSRR by 1
surgeon (J.S.I.). Of these 70 patients, those with bicuspid aortic valves
(n ¼ 22) were excluded. For the remaining 48 patients (12 women and
36 men), the age range was 21 to 77 years. We compared these 48
VSRR procedures with 15 BVC procedures performed with the Carpentier
Edwards Pericardial valve (Edwards Lifesciences Corp, Irvine, Calif)
during the same period and by the same surgeon (J.S.I.). In the VSRR
group, the etiology of the aortic root aneurysm was degenerative in most
patients (n ¼ 43) and aortic dissection in 5. Of the 15 BVC patients, the
indication for surgery was degenerative disease in 12 and dissection in 3.diovascular Surgery c Volume 148, Number 6 2883
Abbreviations and Acronyms
BVC ¼ bioprosthetic valve conduit
NYHA ¼ New York Heart Association
VSRR ¼ valve sparing root replacement
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DAll patients had aortic root aneurysmal disease that met standard size
criteria (ie,>5.0 cm diameter or>2 times the size of a normal aortic
segment) for resection. However, the greatest disparity between the 2
groups was patient age. Therefore, the 15 BVC patients were matched
by age with 16 of the older VSRR patients. Data were collected
prospectively as a part of our institutional participation in the Society of
Thoracic Surgeons database and retrospectively from a review of the
medical records for additional information not obtained prospectively.
The preoperative patient characteristics are listed in Table 1, and the
intraoperative variables are listed in Table 2.
The institutional review board of the Medical University of South
Carolina approved the present study and waived the need for individual
patient consent.
Operative Technique
VSRRwas performed as described previously.7 In brief, cannulation for
cardiopulmonary bypass was obtained by way of the ascending aorta and
right atrial appendage. Cardiac arrest was achieved with a combination
of antegrade and retrograde cold blood cardioplegia. After transection of
the ascending aortic aneurysm, the aortic valve was inspected for
pathologic features that might preclude its preservation. When the valve
was deemed acceptable for preservation (nonsclerotic without obvious
large fenestrations or other imperfections), the aneurysm was excised,
leaving a 5- to 8-mm rim of aortic tissue around the native valve and around
the coronary ostia. Next, horizontal mattress sutures were placed circum-
ferentially under the aortic valve annulus from inside to out and across
an appropriately sized Dacron graft (Hemashield; Meadox Medicals,
Oakland, NY; and Dacron; DuPont, Wilmington, Del). Graft sizing was
achieved by adding 11 mm to the Hegar dilator-sized annulus (2.5-mm
allowance for aortic wall thickness on either side of the outflow graft
[5 mm total] and 6 mm for billowing of the neosinus graft). The Dacron
graft was seated such that the valve was contained within the graft. The
sutures were tied with an appropriately sized Hegar dilator gently placed
across the aortic valve (to prevent overplication of the graft and constriction
of the annulus and left ventricular outflow tract) and cut. The valvewas then
attached to the wall of the Dacron graft using running polypropylene suture
followed by reimplantation of the coronary arteries in anatomic fashion.
After re-establishment of arterial continuity, the patients were warmed
and weaned from cardiopulmonary bypass.
The stented pericardial BVC was performed by first excising the native
aortic leaflets and fashioning coronary buttons in the usual manner.
Everting pledgeted mattress sutures were placed circumferentially around
the annulus. The valve conduit was then constructed using running
horizontal mattress sutures to affix an appropriately sized pericardial valve
within a Dacron graft approximately 10 cm long. Root replacement
proceeded as usual.
Statistical Analysis
The variables compared included demographic data, preoperative
risk factors, intraoperative measures, and postoperative outcomes.
The normality of the continuous variables was evaluated using the
Kolmogorov-Smirnov statistic, and between-group comparisons were
performed using the Student t or Mann-Whitney U test, as appropriate.
Fisher’s exact test was used to examine categorical variables. All tests
were performed using SPSS 22 (SPSS Inc, Chicago Ill).2884 The Journal of Thoracic and Cardiovascular SurRESULTS
Patient demographics, operative characteristics, and early
postoperative outcomes are summarized inTables 1, 2, and 3,
respectively. The greatest disparity between the VSRR and
BVC groups was age (55 vs 69 years, respectively;
P< .0005). Therefore, the 16 oldest VSRR patients were
matched by age with the 15 BVC patients. These patients
were similar in height, weight, sex, and race and differed
only in the use of concomitant coronary artery bypass
grafting (2 VSRR and 7 BVC; P ¼ .036). Within the 31-
matched patients, the indication for surgery was dissection
in no VSRR patient and 3 BVC patients (P ¼ .224). In the
VSRR group, 11 patients were in New York Heart
Association (NYHA) class I or II and 5 were in NYHA class
III or IV preoperatively. In the BVC group, 4 patients were in
NYHA class I or II and 11 were in NYHA class III or IV pre-
operatively. At 1 year postoperatively (approximate, given
scheduling of follow-up visits), 100% of the VSRR group
(n ¼ 14, 2 were lost to follow-up) were NYHA class I, and
in the BVC group, 13 were NYHA class I or II and 1 was
in NYHA class III (Figure 1). The cardiopulmonary bypass,
crossclamp, and circulatory arrest times were not different
between the VSRR and BVC groups (174 vs 187 minutes,
P ¼ .205; 128 vs 133 minutes, P ¼ .376; and 10 vs 13 mi-
nutes, respectively; P ¼ .175). No differences were found
with respect to postoperative complications. One death
occurred in the BVC group and none in the VSRR group.
Two permanent strokes occurred in the BVC group and
none in the VSRR group. The intensive care unit length of
stay was significantly shorter in the VSRR group (54 vs
110 hours;P¼ .001), as was the overall postoperative length
of stay (6 vs 8 days;P¼ .038). The cause of immunocompro-
mise in the VSRR patient was treatment of ulcerative colitis.
The reasons for previous surgery in the VSRR group were
endocarditis in 1 patient and ascending aorta replacement
for aneurysm in 1 patient. The reasons for previous surgery
in the BVC group was pulmonary autograft dilation after
Ross in 1 patient, previous root replacement with a St Jude
conduit in 1 patient, and previous repair of traumatic de-
scending aortic tear in 1 patient (Table 1). The reasons for
prolonged length of stay included pulmonary embolus in 1,
pneumonia in 3, stroke in 1, atrial fibrillation in 1, and reop-
eration for bleeding in 1. The transvalvular gradients were
lower in the VSRR group (6 vs 11.4 mm Hg; P ¼ .001;
Figure 2). Postoperative aortic insufficiency was graded
as none in 7, trace in 3, mild in 5, and not recorded in
1 VSRR patient. It was graded as none in 14 and not
recorded in 1 BVC patient.DISCUSSION
In older patients, the perceived risks of VSRR might
appear to outweigh the benefits of this technically
challenging procedure. The results of the present studygery c December 2014
TABLE 1. Patient demographic data and risk factors
Variable
VSRR
(n ¼ 16)
BVC
(n ¼ 15)
P
value
Age (y) 65  20 69  7 .079
Height (cm) 176  9 175  13 .803
Weight (kg) 84  11 88  19 .532
BSA (m2) 2.00  0.17 2.03  0.27 .760
Etiology .101
Dissection 0 (0) 3 (20)
Aneurysm 16 (100) 12 (80)
Angiographically proven CAD .162
Normal arteries 9 (56) 3 (20)
Nonobstructive CAD 3 (19) 4 (27)
Obstructive CAD 3 (19) 7 (47)
Unknown 1 (6) 1 (7)
Reoperation 2 (13) 3 (20) .654
Elective status 15 (94) 13 (87) .600
Current smoker 3 (19) 2 (13) 1.000
Diabetes 2 (13) 3 (20) .654
Dyslipidemia 10 (63) 10 (67) 1.000
Hypertension 14 (88) 14 (93) 1.000
Endocarditis 0 (0) 1 (7) .484
COPD 2 (13) 1 (7) 1.000
Immunocompromise 1 (6) 0 (0) 1.000
PVD 1 (6) 2 (13) .600
Previous MI 1 (6) 0 (0) 1.000
CVA 1 (6) 0 (0) 1.000
Angina 2 (13) 3 (20) .654
Arrhythmia 4 (25) 1 (7) .333
Data presented as mean  standard deviation or n (%). VSRR, Valve sparing
root replacement; BVC, bioprosthetic valve conduit; BSA, body surface area;
CAD, coronary artery disease; PVD, peripheral vascular disease; MI, myocardial
infarction; CVA, cerebrovascular disease; COPD, chronic obstructive pulomonary
disease.
TABLE 2. Operative characteristics
Variable
VSRR
(n ¼ 16)
BVC
(n ¼ 15)
P
value
Concomitant CABG .036
None 14 (88) 8 (53)
Single vessel 2 (13) 5 (33)
Double vessel 0 (0) 2 (13)
CPB (min) .205
Mean  SD 174  26 187  32
Median 169 180
Range 144-262 143-260
Crossclamp time (min) .376
Mean  SD 128  12 133  22
Median 125 134
Range 109-152 92-177
Circulatory arrest time (min) .175
Mean  SD 10  2 13  7
Median 10 11
Range 7-15 6-35
Valve/Hegar size (mm) .048
Median 22 25
Range 20-25 21-27
Valve/Hegar size indexed to BSA 11.1  0.6 11.9  1.4 .060
Aortic root graft size <.0005
Median 34 28
Range 26-36 26-34
Data presented as n (%) or mean SD, unless otherwise noted. VSRR, Valve sparing
root replacement; BVC, bioprosthetic valve conduit; CABG, coronary artery bypass
grafting; CPB, cardiopulmonary bypass; SD, standard deviation; BSA, body surface
area.
FIGURE 1. New York Heart Association (NYHA) class preoperatively
(Pre-op) and 1-year postoperatively (Post-op) in the valve sparing root
replacement (VSRR) and bioprosthetic valve conduit (BVC) groups. The
number of patients is indicated at the top of each bar. Two VSRR patients
were lost to follow-up before 1 year postoperatively, and 1 BVC patient
died intraoperatively.
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BVC in older patients with aortic root aneurysm. BVC has
previously been considered the standard of care for aortic
root aneurysm. However, approximately 30% of the pa-
tients who undergo aortic root replacement will have a
morphologically normal aortic valve.7 The possibility of
sparing the native aortic valve affords the patient the
freedom from the inherent drawbacks of a valved conduit
(ie, the need for anticoagulation in the case of a mechanical
prosthesis and the theoretical risk of structural deterioration
in the case of a biologic valve).
Limited data are available comparing the VSRR proce-
dure and that of a valved conduit for aortic root aneurysm.
In 2001, Kallenbach and colleagues6 reported a comparison
of VSRR and mechanical valve conduit replacement. Of
note, the operative times were shorter and bleeding
complications more frequent in the valve conduit
replacement group. In contrast, a single patient in the
VSRR group required reoperation for valve failure.6 Since
then, no reports have been published comparing modern
VSRR and valve conduit replacement. Compared with the
results from Kallenbach and colleagues,6 our circulatoryThe Journal of Thoracic and Cararrest times were considerably shorter (19 and 25 minutes
in their study vs 10 and 13 minutes in our study for the
VSRR and BVC groups, respectively). Furthermore, in
our cohort, the overall hospital length of stay was
significantly shorter (18 and 21 days vs 6 and 8 in ourdiovascular Surgery c Volume 148, Number 6 2885
TABLE 3. Early postoperative outcomes
Variable
VSRR
(n ¼ 16)
BVC
(n ¼ 15)
P
value
Reoperation for bleeding 0 (0) 1 (7) 1.000
Sepsis 0 (0) 1 (7) 1.000
Permanent stroke 0 (0) 2 (13) .483
Ventilator prolonged 1 (7) 2 (13) 1.000
Pulmonary embolism 1 (7) 0 (0) 1.000
Pneumonia 0 (0) 1 (7) 1.000
Renal failure 0 (0) 1 (7) 1.000
Operative death 0 (0) 1 (7) 1.000
Mortality or major morbidity 2 (13) 5 (33) .390
Reoperation for pacemaker
implantation
0 (0) 1 (7) 1.000
Atrial fibrillation 4 (25) 6 (40) .458
ICU LOS (h) .001
Mean  SD 54  45 110  38
Median 45 120
Range 18-173 51-166
Total LOS (d) .019
Mean  SD 7  2 10  6
Median 6 9
Range 4-12 5-27
Postoperative LOS (d) .038
Mean  SD 6  2 8  3
Median 6 8
Range 4-11 4-16
Postoperative gradient (mm Hg) .001
Mean  SD 6.0  2.4 11.4  4.5
Median 5.6 10.0
Range 1.9-11.0 6.0-18.0
Postoperative AI (immediately
postoperatively)
.004
None 7 (44) 14 (93)
Trace 3 (19) 0 (0)
Mild 5 (31) 0 (0)
Not recorded 1 (6) 1 (7)
Data presented as n (%), unless otherwise noted. VSRR, Valve sparing
root replacement; BVC, bioprosthetic valve conduit; SD, standard deviation;
ICU, intensive care unit; LOS, length of stay; AI, aortic insufficiency.
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FIGURE 2. Aortic valve gradients in valve sparing root replacement
(VSRR) and bioprosthetic valved conduit (BVC) groups.
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DVSRR and BVC groups, respectively) despite our patients
being nearly 1 decade older. These improvements might
have resulted from improvements in the surgical technique
and postoperative care over time because their report preda-
ted ours by 12 years. None of our patients required
reoperation for bleeding compared with 9 total reoperations
in the study by Kallenbach and colleagues6 for bleeding,
pacemaker implantation, and subxiphoid drainage. The
transvalvular gradients were not reported in their study6;
however, we found lower gradients in the VSRR group
(6 vs 11.4 mm Hg for VSRR and BVC, respectively;
Figure 2). Aortic insufficiency was mild or less in all
VSRR patients on the postoperative echocardiogram, with
more than one half of those patients having no insufficiency
detectable. Not surprisingly, aortic insufficiency was not
identified in any of the BVC patients postoperatively.
A number of others have published their experience in us-
ing either BVC or valve-sparing techniques in treating
similar patients. Moorjani and colleagues8 compared their
experience with a commercially available prefabricated
valved conduit versus a hand-sewn BVC, such as was
used in the present study. They found less bleeding, a lower
requirement for transfusion, and similar gradients
immediately postoperatively with the commercially
available aortic root prosthesis.8 Subramanian and
colleagues9 retrospectively compared the outcomes of
patients with acute type A dissection and found similar
long-term results, including the degree of postoperative
aortic insufficiency and overall survival between patients
who had undergone a Bentall procedure and those who
had undergone a Yacoub or David VSRR. Cameron and
collagues10 reviewed the Johns Hopkins experience using
various methods of aortic root replacement in patients
with Marfan disease. During the 30-year course of their
retrospective analysis, the frequency of VSRR exceeded
that of the modified Bentall during the last 8 years (1998-
2006). They concluded that the durability of valve-sparing2886 The Journal of Thoracic and Cardiovascular Surprocedures had not yet proved equivalent over the long
term.10 Finally, the work of Etz and colleagues11 adds a
notable observation to the published data in that of 275
patients who underwent aortic root replacement with
bovine pericardial valved conduits, a single patient had
required reoperation for structural degeneration of the valve
at 12 years postoperatively.
The present study had several important limitations. It
was retrospective and therefore subject to significant bias.
The decision to proceed with VSRR or BVC was at the
discretion of the attending surgeon and might have been
influenced by concomitant procedures or perceived surgical
risk. Almost one half of the BVC patients (47%) had
undergone concomitant coronary artery bypass grafting,
which artificially increased the operative, bypass, andgery c December 2014
DeNino et al Acquired Cardiovascular Diseasecrossclamp times for this group. There were 3 dissections in
the BVC group compared with none in the VSRR group.
Long-term follow-up data, specifically echocardiographic
follow-up data, were not available to determine whether
the older VSRR recipients benefited as fully as did younger
VSRR patients from this procedure. Finally, the exclusive
use of the Carpentier Edwards pericardial valves in the pre-
sent series might have resulted in higher or lower valvular
gradients, depending on whether an alternative valve or
conduit (homograft, stentless root) had been selected.CONCLUSIONS
Our experience has shown that in older patients, a
technically more challenging approach to the aortic root,
compared with BVC, can be undertaken, with similar
operative times and overall morbidity and mortality, shorter
hospital stays, and superior postoperative hemodynamic
results, avoiding the potential morbidity associated with an-
ticoagulation for mechanical valves. However, our findings
cannot yet be generalized to all patients with aortic root
aneurysm. Therefore, more research is needed to determine
whether this is an appropriate procedure for older patients
undergoing high-risk or concomitant procedures.The Journal of Thoracic and CarReferences
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